Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Depression 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Prostatic Hyperplasia 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Fatigue 2

Interventions

Bupivacaine 4 Saline Solution 3 Ketamine 3 Transcutaneous Electric Nerve Stimulation 2 Ropivacaine 2 Radiofrequency Ablation 2 Magnesium Sulfate 2 Ketorolac 2 Dexmedetomidine 2 Control Groups 2 Anesthesia, Local 2 Acupuncture Therapy 2 Acetaminophen 2 engage 8200 1 Yoga 1 Varenicline 1 Transdermal Patch 1 Therapeutics 1 Telemedicine 1 Surgical Instruments 1 STAMP-I protocol 1 Radiosurgery 1 Psilocybin 1 Palliative Care 1 Oxycodone 1 Music Therapy 1 Morphine 1 Methods 1 Levobupivacaine 1 Ketoprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Therapeutics × 1 year × Clear all

NCT06947577 2025-08-20

PEMFTEPCHIN

Cairo University

Phase 4 Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡